Cargando…
Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
Cervical cancer is the fourth most common cause of cancer-related deaths in women worldwide. With the development of detection of precancerous lesions and preventive human papillomavirus (HPV) vaccination program, a survival improvement has been observed in these patients in developed countries, alt...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455883/ https://www.ncbi.nlm.nih.gov/pubmed/28607581 http://dx.doi.org/10.1177/1758834017708742 |